Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H30OS |
Molecular Weight | 306.506 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@]3([H])CC[C@@]4([H])[C@]5([H])CC[C@H](O)[C@@]5(C)CC[C@]4([H])[C@@]3(C)C[C@@]1([H])S2
InChI
InChIKey=OBMLHUPNRURLOK-XGRAFVIBSA-N
InChI=1S/C19H30OS/c1-18-8-7-14-12(13(18)5-6-17(18)20)4-3-11-9-15-16(21-15)10-19(11,14)2/h11-17,20H,3-10H2,1-2H3/t11-,12-,13-,14-,15-,16+,17-,18-,19-/m0/s1
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/4740596Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/3023306,
Sources: http://www.ncbi.nlm.nih.gov/pubmed/4740596
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/3023306,
Epitiostanol is androgenic antiestrogen developed for the treatment of breast cancer. The drug inhibits estrogen receptor and activates androgen receptor and was shown to be active in vitro on MCF-7, U-2 and U-3 cells. The current marketing status of Epitiostanol is unknown and is supposed to be "discontimued".
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093866 Sources: http://www.ncbi.nlm.nih.gov/pubmed/4740596 |
0.78 µM [Ki] | ||
Target ID: P10275 Gene ID: 367.0 Gene Symbol: AR Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/4740596 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | THIODROL Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (epitiostanol) on hypothalamo-pituitary-gonadal axis in humans. | 1975 Jan |
|
Absorption and disposition of epithiosteroids in rats (1): Route of administration and plasma levels of epitiostanol. | 1991 Jul |
|
Progesterone receptor membrane component-1 regulates hepcidin biosynthesis. | 2016 Jan |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3023306
MCF-7, U-2 and U-3 cell lines were treated with Epitiostanol to test the cells resistance. EC50 values were 3*10(-8), 3*10(-5) and 3*10(-5) M, respectively.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2360
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
||
|
NCI_THESAURUS |
C243
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m4950
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
2363-58-8
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
C1089
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
3530
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
C002976
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
YE7586973L
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106161
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
100000080494
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
194684
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
EPITIOSTANOL
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
3181
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
DTXSID2045367
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
443935
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY | |||
|
SUB06572MIG
Created by
admin on Fri Dec 15 15:03:06 GMT 2023 , Edited by admin on Fri Dec 15 15:03:06 GMT 2023
|
PRIMARY |
ACTIVE MOIETY